192 related articles for article (PubMed ID: 25333434)
1. Central line-associated bloodstream infections in neonates with gastrointestinal conditions: developing a candidate definition for mucosal barrier injury bloodstream infections.
Coffin SE; Klieger SB; Duggan C; Huskins WC; Milstone AM; Potter-Bynoe G; Raphael B; Sandora TJ; Song X; Zerr DM; Lee GM;
Infect Control Hosp Epidemiol; 2014 Nov; 35(11):1391-9. PubMed ID: 25333434
[TBL] [Abstract][Full Text] [Related]
2. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
See I; Iwamoto M; Allen-Bridson K; Horan T; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):769-76. PubMed ID: 23838215
[TBL] [Abstract][Full Text] [Related]
3. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients.
Metzger KE; Rucker Y; Callaghan M; Churchill M; Jovanovic BD; Zembower TR; Bolon MK
Infect Control Hosp Epidemiol; 2015 Feb; 36(2):119-24. PubMed ID: 25632993
[TBL] [Abstract][Full Text] [Related]
4. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
5. The Centers for Disease Control and Prevention definition of mucosal barrier injury-associated bloodstream infection improves accurate detection of preventable bacteremia rates at a pediatric cancer center in a low- to middle-income country.
Torres D; González ML; Loera A; Aguilera M; Relyea G; Aristizabal P; Caniza MA
Am J Infect Control; 2016 Apr; 44(4):432-7. PubMed ID: 26775931
[TBL] [Abstract][Full Text] [Related]
6. Central line-associated bloodstream infection in neonatal intensive care units.
Blanchard AC; Fortin E; Rocher I; Moore DL; Frenette C; Tremblay C; Quach C
Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1167-73. PubMed ID: 24113600
[TBL] [Abstract][Full Text] [Related]
7. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013.
Epstein L; See I; Edwards JR; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):2-7. PubMed ID: 26456954
[TBL] [Abstract][Full Text] [Related]
8. Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018.
Hsu HE; Mathew R; Wang R; Broadwell C; Horan K; Jin R; Rhee C; Lee GM
JAMA Pediatr; 2020 Dec; 174(12):1176-1183. PubMed ID: 33017011
[TBL] [Abstract][Full Text] [Related]
9. CLABSI Risk Factors in the NICU: Potential for Prevention: A PICNIC Study.
Dahan M; O'Donnell S; Hebert J; Gonzales M; Lee B; Chandran AU; Woolsey S; Escoredo S; Chinnery H; Quach C
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1446-1452. PubMed ID: 27609629
[TBL] [Abstract][Full Text] [Related]
10. Utility of Electronic Medical Records to Assess the Relationship Between Parenteral Nutrition and Central Line-Associated Bloodstream Infections in Adult Hospitalized Patients.
Ippolito P; Larson EL; Furuya EY; Liu J; Seres DS
JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):929-34. PubMed ID: 24898208
[TBL] [Abstract][Full Text] [Related]
11. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
[TBL] [Abstract][Full Text] [Related]
12. Line days as a determinant of central line-associated bloodstream infections in pediatric patients with tunneled femoral peripherally inserted central catheters.
Koo KSH; Cooper AB; Monroe EJ; Reis J; Shivaram GM; Zerr DM
Pediatr Radiol; 2021 Jul; 51(8):1481-1486. PubMed ID: 33675377
[TBL] [Abstract][Full Text] [Related]
13. Association between parenteral nutrition-containing intravenous lipid emulsion and bloodstream infections in patients with single-lumen central venous access: A secondary analysis of a randomized trial.
Gavin NC; Larsen E; Runnegar N; Mihala G; Keogh S; McMillan D; Ray-Barruel G; Rickard CM
JPEN J Parenter Enteral Nutr; 2023 Aug; 47(6):783-795. PubMed ID: 37288612
[TBL] [Abstract][Full Text] [Related]
14. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
Linder LA; Gerdy C; Jo Y; Wilson A
J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between Parenteral Nutrition and Central Line-Associated Bloodstream Infections: 2009-2014.
Fonseca G; Burgermaster M; Larson E; Seres DS
JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):171-175. PubMed ID: 29505142
[TBL] [Abstract][Full Text] [Related]
16. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients.
Gaur AH; Bundy DG; Werner EJ; Hord JD; Miller MR; Tang L; Lawlor JP; Billett AL;
Infect Control Hosp Epidemiol; 2017 Jun; 38(6):690-696. PubMed ID: 28399945
[TBL] [Abstract][Full Text] [Related]
17. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition.
Steinberg JP; Robichaux C; Tejedor SC; Reyes MD; Jacob JT
Infect Control Hosp Epidemiol; 2013 Feb; 34(2):171-5. PubMed ID: 23295563
[TBL] [Abstract][Full Text] [Related]
18. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury.
Chaftari AM; Jordan M; Hachem R; Al Hamal Z; Jiang Y; Yousif A; Garoge K; Deshmukh P; Raad I
Am J Infect Control; 2016 Aug; 44(8):931-4. PubMed ID: 27112370
[TBL] [Abstract][Full Text] [Related]
19. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for central line-associated bloodstream infections in children with tunneled central venous catheters.
Paioni P; Kuhn S; Strässle Y; Seifert B; Berger C
Am J Infect Control; 2020 Jan; 48(1):33-39. PubMed ID: 31395289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
